Table 3.
EBV-associated T-cell lymphomas in immunocompetent hosts
| Lymphoma | EBV frequency | Latency Program |
|---|---|---|
| Angioimmunoblastic T-cell lymphoma | >90% | Type 2 |
| Extranodal NK/T-cell lymphoma, nasal type | 100% | Type 2 |
| Aggressive NK cell leukemia | >90% | Type 2 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.